Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

2-Arylquinolines selectively relax urethral smooth muscle according to recent patent

July 19, 2001

Alpha1A-adrenoceptor blockade not associated with improvement in MED

July 17, 2001

Rational design of mesangial cell proliferation inhibitors

July 16, 2001

Lilly Icos seeks European approval of Cialis for treatment of erectile dysfunction

July 13, 2001

Tricyclic PCOs reported by Abbott, particularly useful in bladder disorders

July 10, 2001

Ixense/Uprima launched in Germany, France and Spain for treatment of ED

July 10, 2001

Beta3-adrenoceptor agonists from Fujisawa particularly useful for urinary incontinence, pollakiuria

July 6, 2001

Selective beta3-adrenoceptor agonists designed at Kissei

July 3, 2001

NexMed launches Befar in China

July 3, 2001

MacroChem completes phase III trial of Topiglan for treatment of ED

July 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...